Article

Another SABCS comes to a close

Author(s):

Well, another great year of SABCS has come to a close. Almost 8,000 people attended the meeting, with 58 percent coming from other parts of the world. Citizens from 94 countries were counted.This symposium has truly become one of the most significant international meetings for those interested in breast cancer. I hope that our coverage of this year's symposium has made you feel that you had a "courtside" seat to all of the important data presented here. I also hope you got to know the CURE team a little better. Now, I would appreciate hearing from you! What did you like, not like about this year's coverage? What can we do better next year? Is there something that really resonated with you? We want to hear it all so we can continue to be here for you at precisely the right time, the right place and in the right format.

Related Videos
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
a man and a woman in front of a dark blue background for CURE Speaking Out
Image of woman.
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of woman with blonde hair.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Related Content